The role of GFP in recombinant DNA technology has gained much attention in the recent years. This is mainly due to the fact that the GFP molecules are much larger than the other RNAs and thus making them easier to process. Moreover, the nucleic acid bases used in this method of genetic engineering have the property to create a double-stranded DNA structure, which can then be inserted into a host sequence of DNA in a precise manner. The first reports of the application of this method were in 1998, followed by a series of scientific studies in the last few years.
Repetitive regions of the DNA code are called repeats, and the method of genetic engineering seeks to use sequences of DNA that share similarities in their construction. The first reports of the use of GFP in this context came from biotechnology organizations based in Europe. There, research work was done on the basis of mouse embryonic stem cells, deriving the useful result of inserting the GFP as the genetic basis for establishing specific types of clones. It was found that the method offered a significant improvement over the conventional methods of gene therapy, and with further research work, it has emerged as an effective medical procedure for establishing various types of clones of several tissues, organs, even blood cells.
Recombinant DNA Technology
In order to understand the role of GFP in recombinant DNA technology, it is important to take a look at the basic principles underlying the method. Basically, when two strands of DNA are united by a DNA glue, then the resulting sequence is termed as a clone. Clones are formed when the same genetic template is repeated multiple times within the genetic material. Such repeated patterns can arise due to errors in transcription or copying, and these errors lead to mutations that are later on detected and identified. Using the cloning system, scientists can generate exact copies of the genetic material required for the creation of the desired trait and hence, facilitating the introduction of genetic materials through insertion into a host system. The method is widely used for the study of genetics and is also useful for developing therapeutic proteins and antibodies.
The study of the role of gap in recombinant DNA technology opens up several avenues for the pharmaceutical industry. This technology can be used to develop drugs that target a single symptom or illness. Scientists can also use the cloning method for the study of the role of gap in immunity and other aspects of the disease process. Hence, the results generated using the technique can be applied to the field of immunology and other health science fields. This will help determine the nature of the immune response and help to design improved drugs.
Another use of the method involves the study of the effects of small genetic changes in the genetic code. This can help to design better strategies for the design of medicines. The study of the role of gap in recombinant DNA technology is still at an early stage, and many challenges remain before it can be mastered. It will be interesting to follow the developments in this field with the increasing number of patents awarded on the method. As this technology gains more popularity, the chances of having this system commercially available in the near future will be high.
As this method of gene expression continues to develop, the knowledge about its potential applications will be increasing. The benefits offered by the system will be considerable if the role of gfp in recombinant DNA technology is properly understood. This will in turn have a profound impact on the field. All the research and effort will not be in vain if the right tools and technologies are making available to the field. In addition, the field will be able to realize its goals with the help of the application of this powerful method of gene expression.
